|
2024 Value-Added Medicines Week |
|
VAMs 2.0: AI-Enabled Development & Commercialization
|
October 21-25, 2024 |
Don't miss VAM Week 2024, your online conference exploring the future of Value-Added Medicines (VAMs)! This year's theme, VAMs 2.0: AI-Enabled Development & Commercialization, dives deep into how Artificial Intelligence (AI) is transforming the VAM landscape.
October 21-25, 2024
Learn more from experts in Value-Added Medicines, register for free today.
VAM Week is a week-long conference dedicated to furthering the understanding of development, approval and commercialization value-added medicines. This premier open-access conference brings together regulators, developers and marketers of value-added medicines.
During VAM Week 2024, regulators, sponsors, and payers will convene to discuss the state of value-added medicine development, access, marketing, and utilization. This year an esteemed faculty of experts from FDA, industry, healthcare providers and other healthcare organizations will share perspectives on what success and progress looks like in value-added medicines both in the US and around the world. Learn more
During VAM Week 2024, regulators, sponsors, and payers will convene to discuss the state of value-added medicine development, access, marketing, and utilization. This year an esteemed faculty of experts from FDA, industry, healthcare providers and other healthcare organizations will share perspectives on what success and progress looks like in value-added medicines both in the US and around the world. Learn more
Value Added Medicines are products that are designed to improve the delivery of state of the art healthcare and patient treatment outcomes. Value-added medicines are designed to be patient centric and deliver increased value to the healthcare system:
